Sign inGet started

Beyer Russell P

Insider CIK 1889754 · SABS Chief Financial Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
SABS SAB Biotherapeutics, Inc. A Award deriv2023-03-142023-03-16275,000— $0275,000SEC↗
SABS SAB Biotherapeutics, Inc. A Award deriv2022-09-132022-09-15274,875— $0274,875SEC↗
SABS SAB Biotherapeutics, Inc. A Award deriv2022-03-162022-03-186,000— $06,000SEC↗
SABS SAB Biotherapeutics, Inc. A Award deriv2021-11-172021-11-19110,000— $0110,000SEC↗
SABS SAB Biotherapeutics, Inc. S Sale2021-10-262021-11-16278$7.90 $2.2K0SEC↗
SABS SAB Biotherapeutics, Inc. A Award2021-10-252021-11-16129$7.78 $1.0K278SEC↗
SABS SAB Biotherapeutics, Inc. A Award2021-10-182021-11-162,475$10.10 $25.0K2,475SEC↗
SABS SAB Biotherapeutics, Inc. A Award2021-09-292021-11-1610$10.08 $10115SEC↗
SABS SAB Biotherapeutics, Inc. A Award2021-09-282021-11-16149$10.08 $1.5K149SEC↗
SABS SAB Biotherapeutics, Inc. A Award2021-09-282021-11-165$10.07 $505SEC↗